Applied BioCode Corp
TWSE:6598
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (5.3), the stock would be worth NT$24.44 (11% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.7 | NT$21.95 |
0%
|
| 3-Year Average | 5.3 | NT$24.44 |
+11%
|
| 5-Year Average | 5.8 | NT$26.77 |
+22%
|
| Industry Average | 2.8 | NT$12.85 |
-41%
|
| Country Average | 1.8 | NT$8.3 |
-62%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| TW |
|
Applied BioCode Corp
TWSE:6598
|
2.3B TWD | 4.7 | -11.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 16 | 56.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 3.5 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 4.8 | 37.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 2.9 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 4.1 | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 7.6 | 43.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 1.7 | 18.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 10.4 | 42.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 1.9 | 24 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 5.7 | 20.9 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 1.1 |
| Median | 1.8 |
| 70th Percentile | 3.1 |
| Max | 384 578.4 |
Other Multiples
Applied BioCode Corp
Glance View
Applied BioCode Corp. designs, develops, manufactures and commercializes multiplex testing products for in-vitro diagnostics market. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-09. The firm's main products include digital barcode magnetic beads (BMB), optical analyzers, in vitro diagnostic reagents and others. The firm sells in the United States, Europe and Asia markets.
